Showing 1 - 10 of 16
There are divergent views on what capacity development might mean in relation to agricultural biotechnology. The core of this debate is whether this should involve the development of human capital and research infrastructure, or whether it should encompass a wider range of activities which also...
Persistent link: https://www.econbiz.de/10010856319
We review the literature on national innovation systems. We first focus on the emergence of the concept of innovation systems, reviewing its historical origins and three main flavours (associated to three "founding fathers" of the concept). After this, we discuss how the notion of innovation...
Persistent link: https://www.econbiz.de/10010856480
Innovation dynamics in Tuberculosis control in India: The shift to new partnerships Tuberculosis remains the biggest infectious killer in India and worldwide, and it has recently regained substantial international attention with its come-back in drug resistant forms. The environment, the disease...
Persistent link: https://www.econbiz.de/10010712067
The present paper examines how a developing country like India is competing in the nanotechnology race. Our study shows that both upstream scientific and technological capabilities and downstream regulatory capabilities are being strengthened. India has clearly made a dent in terms of scientific...
Persistent link: https://www.econbiz.de/10010712077
This paper highlights the great diversity in development pathways and trajectories of innovation across European regions. A regional knowledge-based economy has multi-dimensional aspects. It includes a variety of knowledge activities and multiple interactions among a range of actors including...
Persistent link: https://www.econbiz.de/10010712134
Tuberculosis remains the biggest infectious killer in India and worldwide, and it has recently regained substantial international attention with its come-back in drug resistant forms. The environment, the disease and the societal response to it are changing and with it challenges and...
Persistent link: https://www.econbiz.de/10010712313
The Indian pharmaceutical industry is presently going through a phase of transition and potential consolidation, owing to India's new TRIPS-compliant intellectual property regime and other rules aimed at enhancing the industry's credibility nationally and internationally. Appropriate policy...
Persistent link: https://www.econbiz.de/10010856422
This article first reviews the economic rationales for innovation policy. It then describes the Finnish innovation policy and policy making environment. The Finnish policy is evaluated from the point of view of fostering entrepreneurship. R&D subsidies, the main tool of Finnish innovation...
Persistent link: https://www.econbiz.de/10010856477
Since the mid-twentieth century, the national objective of India and Brazil has been to develop industrial capabilities in essential sectors such as pharmaceuticals. At the outset, they shared some common features: a considerable period of lax intellectual property rights regimes, large internal...
Persistent link: https://www.econbiz.de/10010712130
This paper examines whether the government support in favour of firms located in the Haidian district of Beijing, which includes the Zhongguancun Science Park, was effective in terms of innovation and economic performance. We use a dataset of 500 manufacturing firms that results from a merger of...
Persistent link: https://www.econbiz.de/10010712232